Oct. 17, 2025
| Today’s news and insights for medtech leaders
Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.
|
The investment values the smart-ring maker at $11 billion.
|
The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion of its technology.
|
Analysts expect that DePuy Synthes could become a stronger competitor as a standalone company.
|
Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall Street consensus expectations.
|
|
Device comfort and performance hinge on one critical component: the right wearable adhesive. Learn how early wear studies can differentiate your device and boost market success in this webinar.
|
|
From Our Library
Webinar - on demand
Custom content for Avery Dennison
|
Playbook
Custom content for Werner
|
Trendline
Supported by UFP Technologies Inc.
|
Playbook
Custom content for McKesson
|
View all resources
What We're Reading
Fierce Biotech
| | 
